GSK to invest over $800 million in Pennsylvania, creating 300 new jobs
GlaxoSmithKline announced a capital investment of more than $800 million to expand its facilities in Montgomery County, Pennsylvania. The project will add about 300 jobs over the next five years while retaining roughly 4,500 existing positions. Construction is slated to begin in 2027, and the expansion follows a prior $800 million investment in Lancaster County, bringing total state spending to nearly $1.7 billion.
Why it matters
The investment increases GSK's U.S. manufacturing capacity and may boost its long‑term supply chain resilience. The project also brings tax incentives under Pennsylvania’s QMIRD and Manufacturing Tax Credit programs, which could improve the company’s cost structure.
Key facts
- 1GSK will invest more than $800 million in the Pennsylvania expansion. seekingalpha.com
- 2The expansion will create about 300 new jobs over five years. seekingalpha.com
- 3GSK currently employs roughly 4,500 full‑time workers in Pennsylvania, which will be retained. wfmz.com
- 4Construction of the new facilities is planned to start in 2027. wfmz.com
- 5This is GSK’s second major Pennsylvania expansion, the first in October 2024, bringing total state investment to nearly $1.7 billion. wfmz.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.